Nippon India Pharma Fund vs DSP Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
DSP Healthcare Fund - Regular Plan - Growth
Chart Comparison
Overview
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹8459 Cr | ₹3179 Cr |
| Min Investment | ₹5000 | ₹100 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹100 |
| Launch Date | 05 Jun 2004 | 30 Nov 2018 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | 21% | 18% |
| Expense Ratio | 1.82 | 1.9 |
| Manager | Sailesh Raj Bhan | Jay Kothari |
| ISIN Code | INF204K01968 | INF740KA1LD8 |
| Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | DSP Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 1 Month | -1.62% | -0.54% |
| 6 Month | 1.58% | 2.91% |
| 1 Year | -1.45% | -4.82% |
| 3 Year | 21.6% | 21.34% |
| 5 Year | 15.35% | 15.54% |
SIP Return Analysis
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 6 Month | -1.66% | -1.11% |
| 1 Year | 2.66% | 2.35% |
| 3 Year | 15.82% | 16.04% |
| 5 Year | 16.04% | 16.58% |
Rolling Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 1 Year | 16.62% | 24.12% |
| 3 Year | 20.93% | 21.31% |
| 5 Year | 20.36% | 25.63% |
Risk Management
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Standard Deviation | 15.23% | 14.59% |
| Sharp | 0.92% | 0.94% |
| Beta | 0.91% | 0.84% |
| Alpha | -0.55% | 0.30% |
Fund Managers
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Name | Sailesh Raj Bhan | Jay Kothari |
| Total AUM | ₹96086 Cr | ₹0 Cr |
| Funds Managed | 5 | 20 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
Market Cap
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Others | 1.34 | 20.45 |
| Mid Cap | 35.32 | 14.41 |
| Small Cap | 30.74 | 47.66 |
| Large Cap | 32.6 | 17.47 |
Sector Allocation
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Others | 0.55 | 2.94 |
| Healthcare | 99.45 | 95.57 |
| Financial Services | - | 1.5 |
Top Comparisons
Aditya Birla Sun Life Global Emerging Opportunities Fund - Regular Plan - Growth Option
3Y Returns14.48%
Axis NASDAQ 100 Fund of Fund - Regular Plan - Growth
3Y Returns34.09%
ICICI Prudential Savings Fund - Growth
3Y Returns7.74%
Canara Robeco Savings Fund - Regular Plan - Growth Option
3Y Returns7.17%
Kotak US Specific Equity Passive FOF - Regular Plan - Growth
3Y Returns34.99%
Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth
3Y Returns36.89%
Franklin India Dynamic Asset Allocation Active Fund of Funds-Growth
3Y Returns12.64%
Bandhan Aggressive Hybrid Passive FOF - Regular Plan - Growth
3Y Returns14.09%